Oppenheimer Initiates Omnicell With Outperform

Analysts at Oppenheimer initiated coverage on

with a Outperform rating. The target price for Omnicell is set to $44. Omnicell shares have gained 40.17 percent over the past 52 weeks, while the S&P 500 index has surged 7.19 percent in the same period. Omnicell shares declined 0.31 percent to close at $38.63 yesterday.